2025-12-05
Southeast Asia's leading financial education technology group, 8I Holdings Limited, officially announced a strategic partnership with globally renowned online brokerage firm Webull to jointly develop and launch the revolutionary intelligent investment system – VI+ 3R System. The platform has officially received regulatory approval (License No.: eCMSL/A0399/2024), marking the official start of a new era of compliant, transparent, and efficient intelligent investment.
The VI+ 3R System perfectly addresses investors' pain points of "difficult stock selection and weak risk control." It deeply integrates VI College's exclusive value investing algorithm with top-tier trading technology from securities firms. Through its built-in "Risk-Adjusted Matrix," it allows investors to gain an institutional-level perspective on the market. Real-world testing shows that the system effectively filters out 90% of low-quality assets, ensuring that every transaction is based on data and is truly effective.
This collaboration is a powerful engine for 8I's flagship project, the "Infinite Wealth Plan." This plan aims to break the mindset of ordinary people who rely on "labor for income," advocating for the creation of passive income through systematic tools. Having the VI+ 3R System means that investors are no longer entering the stock market empty-handed, but rather possess the "super weapon" of the top-tier wealthy.
Clive Tan, co-founder of 8I Holdings, said, “Financial freedom should not be the privilege of the rich. Through the Infinite Wealth program and the VI+ 3R System, we want to empower every ordinary person to take control of their money by improving their financial literacy.”
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map